is semaglutide or tirzepatide more effective vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Tirzepatide vs semaglutide for weight
Description
I was expecting to see more GI side effects with the higher dose, but it wasn't too much higher--70.8% at 7.2 mg vs 61.2% at 2.4 mg vs 42.8% with placebo, mostly mild an self-limited
As @Pascal Soriot #Chief #Executive #Officer, AstraZeneca put it: The only thing I will say is that we have a very competitive profile. 3 Phase 3 commitment signals internal confidence According to @Pascal Soriot, the company would not: Enter Phase 3 Fund monotherapy + combination studies Commit to cardiovascular outcome trials unless leadership believed elecoglipron could compete in a brutally crowded oral GLP-1 field

Lets explore five key options for mindful sodium and potassium replenishment.
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.

Ozempic, Wegovy, Mounjaro, and Zepbound are pretty much household names at this point.

CGA treatment also prevented rotenone-induced motor and cognitive impairments and significantly restored the rotenone-induced oxidative stress
